Duration and severity of fatty metamorphosis of the liver following L-asparaginase therapy.
D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects*; D001344:Autopsy; D002648:Child; D005234:Fatty Liver / Q000139:chemically induced* / Q000473:pathology; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D013997:Time Factors
D001215:Asparaginase